VerbatimParliament, as it happens

Diabetes: Research

Asked by Sir John HayesConservativeDepartment for Science, Innovation and TechnologyTabled Answered 10 July 2026UIN 14779

The question

To ask the Secretary of State for Science, Innovation and Technology, what assessment she has made of the UK's position globally in respect of research into beta cell preservation, regeneration and replacement therapies for type 1 diabetes.

Answered by Kanishka Narayan

Through UK Research and Innovation (UKRI), including UKRI’s Medical Research Council (MRC), the Government supports a broad portfolio of research relevant to Type 1 diabetes. This includes work on pancreatic biology, immunology, and cell replacement approaches, alongside wider research into the underlying mechanisms of the disease. Funding is awarded through open, competitive processes based on scientific excellence, ensuring the UK remains well placed to contribute to advances in areas such as beta cell therapies.

The Department of Health and Social Care also funds research through the National Institute for Health and Care Research, which supports high-quality research to improve the diagnosis, treatment and management of Type 1 diabetes.

Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →

Open this question in Verbatim →

Every written question, searchable

155,000 questions tabled since the election, with the answer each department gave — and the ones still unanswered, with the clock running. Free to search.

Search written questions →Read on Verbatim